RxDoctor Payments Data

Heather Leach

Psychiatric/Mental Health · Springdale, ARNPI 1659548105

Payments from drug & device makers

$469in general payments, 2019–2025

Across 23 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$99
  • Otsuka America Pharmaceutical, Inc.$88
  • AbbVie$72
  • Neurocrine Biosciences, Inc.$54
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$35
  • Alkermes, Inc.$29
  • plus $92 from 5 others

What the payments were for

  • Food & beverage$469100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$469 in reported general payments places this provider in the 35th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$8,508
Medicare patients
37
Services billed
103

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate27$65,306
VraylarCariprazine Hcl36$60,048
TrintellixVortioxetine Hydrobromide22$10,809
Lurasidone Hcl35$6,095
Aripiprazole48$5,457
Oxcarbazepine99$3,405
Chlorpromazine Hcl12$2,519
Atomoxetine Hcl27$2,154
Quetiapine Fumarate148$1,977
Paliperidone ErPaliperidone17$1,862
Olanzapine87$1,599
Bupropion XlBupropion Hcl85$1,029
Fluvoxamine Maleate20$967
Hydroxyzine Hcl56$964
Mirtazapine89$876

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$99$65,30627 claims
AbbVieVraylar$72$60,04836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Springdale

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →